-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Science and Technology Daily, Beijing, December 9th (Reporter Zhang Mengran) Scientists at the National Institute of Allergy and Infectious Diseases (NIAID) said that an mRNA-based experimental HIV vaccine shows promise in mice and non-human primates
The experimental vaccine works similarly to the mRNA new coronavirus vaccine, but does not carry the mRNA instructions of the coronavirus spike protein, but provides coding instructions to produce two key HIV proteins-Env and Gag
The researchers reported that in the experiment, two injections of the mRNA vaccine to form the VLP induced neutralizing antibodies in all animals
The research team then tested the Env-Gag VLP mRNA vaccine in rhesus monkeys
Starting from the 60th week, the immunized and non-immunized rhesus monkey control groups were exposed to SIV through the rectal mucosa every week
Editor-in-chief
Despite nearly four years of efforts by scientists around the world, an effective vaccine to prevent HIV is still an elusive goal